August 2026

85 Articles

Beyond the Guidelines

Imaging-guided dyslipidemia management: Bridging evidence and implementation

11 May 2026
Author(s): Anastasios Kollias, Dimitra Krystallaki, Thomas Tsaganos

Arterial imaging has emerged as an increasingly important component of contemporary cardiovascular prevention strategies, enabling direct assessment of subclinical atherosclerosis and refining... more

Clinical Insights

Emerging evidence from combination therapy reinforces the role of β-blockers in resistant hypertension

2 May 2026
Author(s): Stefano Masi, Claudio Borghi

Resistant hypertension (RHTN) represents a growing clinical challenge, affecting an estimated 10–15% of patients with treated hypertension [1–3]. Its prevalence might increase in the coming years,... more

Commentary

Aldosterone synthase inhibitors in uncontrolled and resistant hypertension: promise, pitfalls, and unanswered questions

30 June 2026
Author(s): Stefano Masi, Alessandra Violet Bacca, Stefano Taddei

Arterial hypertension remains the leading contributor to global morbidity and mortality, yet only a minority of patients achieve adequate blood pressure (BP) control [1]. This persistent gap is... more

Cocaine-induced ANCA-associated vasculitis: A diagnostic challenge at the interface of toxic exposure and autoimmunity

10 June 2026
Author(s): José Hernández-Rodríguez, Mauricio López-Chacón, Isam Alobid

In the current issue of the European Journal of Internal Medicine, Garvín-Grande et al. present a cohort analysis combined with a structured literature review delineating the clinical and... more

Hydroxychloroquine for recurrent pericarditis: Old drug, new role

7 June 2026
Author(s): Clement Tan, Mohammad Alqahtani, Allan Klein

Recurrent pericarditis (RP) has posed a therapeutic challenge, with treatments consisting of nonsteroidal anti-inflammatory drugs, corticosteroids, drug-modifying antirheumatic drugs (DMARDs) and in... more

Beyond categorical exclusion: Reclaiming clinical judgment in the use of JAK inhibitors for rheumatoid arthritis

27 May 2026
Author(s): Nicola Farina, Lorenzo Dagna

The therapeutic landscape for rheumatoid arthritis (RA) has undergone a profound transformation over the last decade, marked by the emergence of Janus kinase inhibitors (JAKi) as highly effective... more

Alcohol use: less is better. Shifting the clinical paradigm from 'safe thresholds' to risk reduction

15 May 2026
Author(s): Carolina L. Haass-Koffler, Stephanie L. Foster

When it comes to alcohol consumption, patients and healthcare providers want to know what amount is considered safe. But given that alcohol is recognized as a Group 1 carcinogen [1], this begs the... more

Pulmonary embolism and long-term survival: the role of comorbidities beyond the acute event

11 May 2026
Author(s): Ludovica Anna Cimini, Maria Cristina Vedovati

Pulmonary embolism (PE) is traditionally considered an acute cardiovascular emergency, with management strategies primarily aimed at reducing early mortality and secondarily at preventing recurrence... more

Social determinants of health in the era of precision medicine

6 May 2026
Author(s): Ludovico Furlan, Giorgio Costantino

“Man is by nature a social creature” Aristoteles used to say.

Corrigendum

Corrigendum to “Role of 12-lead Electrocardiogram for identifying very low mortality risk patients with non-hypotensive acute pulmonary embolism” [European Journal of Internal Medicine 140 (2025) 106373]

5 May 2026
Author(s): Crhistian-Mario Oblitas, Francisco Galeano-Valle, Luis-Antonio Alvarez-Sala Walther, Pablo Demelo-Rodríguez

The authors regret that there is an error in the last row of Table 1, where the wrong information says:

Editorial

The meta-analysis deluge: When synthesis becomes pollution

25 May 2026
Author(s): Samer Al Hadidi

Systematic reviews and meta-analyses have long been heralded as the apex of evidence-based medicine [1]. Positioned at the pinnacle of evidence hierarchies; these methodologies promise to synthesize... more

Ideas and Opinions

Should Ticagrelor in association with aspirin be still considered the standard dual antiplatelet treatment for acute coronary syndromes?

4 May 2026
Author(s): Stefano De Servi, Claudio Montalto, Stefano Savonitto

Ticagrelor, a potent inhibitor of P2Y12 platelet receptor, co-administered with aspirin in dual antiplatelet therapy (DAPT), received marketing authorization from the European Medicines Agency in... more

Internal Medicine Flashcard

Papulonodular rash and destructive palatal lesion with systemic symptoms

23 May 2026
Author(s): Claude Bachmeyer, Philippe Moguelet, Lea Savey

None.

Scurvy in a hemodialysis patient after prolonged hospitalization

5 May 2026
Author(s): Naohiro Muraki, Naoto Hamano, Michiya Shinozaki

A 64-year-old woman with a 38-year history of hemodialysis presented with general weakness. Until 3 days before presentation, she had been hospitalized for one month due to bullous pemphigoid... more

The central dot sign in liver

4 May 2026
Author(s): Qingren Cao, Qing Xie, Zhujun Cao

A 24-year-old man presented with a 2-year history of recurrent epistaxis and fatigue. Laboratory workup revealed persistent pancytopenia (white blood cell count 2.23 × 10⁹/L, platelet count 54 × 10⁹/... more

Multiple hepatic lesions and vascular lakes

2 May 2026
Author(s): Monica Rubio-Ardanaz, Miguel Sogbe, Juan Felipe Lucena

An 86-year-old man with a history of polyarteritis nodosa on long-term corticosteroid therapy and prior splenic rupture requiring surgery presented with asthenia, low-grade fever, and jaundice. A CT... more

An unusual case of skin ulcer

22 April 2026
Author(s): A. Poloni, M. Schiavini, A. Giacomelli

A 29-year-old Italian woman presented at the emergency department with a 65-day history of cutaneous lesion on her left forearm, started while she was on a stay in Bolivia. Initially, the lesion was... more

Encephalitis with the temporal lobe signature

11 April 2026
Author(s): Shashikant Saini, Banerjee Bodhibrata, Navneet Sharma

A 16-year-old boy presented with a fever and decreased responsiveness for one day. There was no history of focal neurological deficits or seizures. On examination, he was hemodynamically stable but... more

Painful leg nodules, fever, and ankle arthralgia in a middle-aged woman

3 April 2026
Author(s): Inês Pereira Amaral, Ivânia Soares, Joana Antunes

A previously healthy 56-year-old woman presented with a 2-week history of painful erythematous-to-violaceous firm subcutaneous nodules involving the anterior and posterior aspects of both legs, with... more

Internal Medicine Flashcards

A hidden cause of sudden epigastric pain in a middle-aged man

4 April 2026
Author(s): Toshimasa Yamaguchi, Yuko Inoue

A 45-year-old man with a history of smoking and dyslipidemia presented with a 3-day history of sudden-onset epigastric pain that occurred while walking. The pain had largely subsided by the time of... more

Invited Review Article

From unmet needs to new possibilities: PPAR-targeted therapies in the journey of people living with Primary Biliary Cholangitis

15 April 2026
Author(s): Antonella Ruiu, Maria Pia Calabrese, Pietro Meschisi, Riccardo Plebani, Maria Buzias, Ana Lleo, Vincenzo Ronca

Primary biliary cholangitis (PBC) is a chronic autoimmune cholestatic liver disease characterized by progressive destruction of the small intrahepatic bile ducts. If is left untreated, the resulting... more

Erectile dysfunction and antihypertensive therapy: A critical reappraisal

9 April 2026
Author(s): Athanasios J Manolis, Manolis S Kallistratos, Maria Koutsaki, Nikolaos Papaioannou, Michael Doumas

Erectile dysfunction often coexists with arterial hypertension. They both share a common vascular pathophysiology, while antihypertensive treatment may also affect sexual function. Although some of... more

Letter to the Editor

Epicardial adipose tissue between biological complexity and clinical readiness

24 June 2026
Author(s): Giovanni Ragozzino, Edi Mattera

Epicardial adipose tissue (EAT) is gaining visibility as an imaging biomarker, yet its clinical maturity remains limited. The recent exchange between Angeli et al. and Momot et al. highlights... more

Evidence of increased awareness in cardiac amyloidosis, but still room for improvement.

30 May 2026
Author(s): Luisa Ojeda-Fernandez, Marta Baviera, Claudio Cimminiello

Dear Editor,

Refining checklist-based screening for transthyretin cardiac amyloidosis: methodological and pathophysiological considerations. Author's reply

27 May 2026
Author(s): Alberto Pérez-Nieva, Pau Llàcer, Prado Salamanca-Bautista, Miquel Camafort, Luis Manzano

We are grateful for the considerations made by Li Nie et al. [1] regarding the CHECKAMIC study [2] and would like to make the following clarifications.

Heart failure and COPD - guideline adherence, diagnostic characterisation and treatment quality

25 May 2026
Author(s): Delphine Vauterin, Nathaniel M. Hawkins, Leonardo M. Fabbri, Lies Lahousse

We thank Steffen et al. for their interest in our study on guideline-directed medical therapy (GDMT) in patients with heart failure (HF) during hospitalised exacerbations (ECOPD) [1,2] We acknowledge... more

Clinically isolated joint involvement is a distinct entity in Whipple’s disease

23 May 2026
Author(s): Victor Eiferman, Xavier Puéchal

We thank Chen et al. for their insightful comments [1] on our cohort study [2]. Previous classifications of Whipple’s disease (WD) have largely been microbiology-driven [3]. Our objective was to... more

Interpreting observational comparisons of DOACs and VKAs in kidney transplant recipients. Author’s reply

22 May 2026
Author(s): Michele Rossi, Gregory Y.H. Lip

We thank Liu et al. [1] for their thoughtful comments regarding the methodological aspects of our study [2].

Systemic inflammation and frailty in cirrhosis: Considerations regarding the role of the systemic immune-inflammation index. Author’s reply

13 May 2026
Author(s): Miguel Sogbe, Astrid Ruiz-Margáin, Andres Duarte-Rojo

We appreciate the thoughtful comments by Güven İE [1] regarding our study evaluating the association between the systemic immune-inflammation index (SII) and frailty in patients with advanced chronic... more

Beyond the absolute value: A critical appraisal of the prognostic everest of lactate ratio in diabetic ketoacidosis

25 April 2026
Author(s): Yuan Yang, Wei Yang

We read with great interest the recent study by Sebastian-Valles F et al. published in the European Journal of Internal Medicine, titled " Pre- and in-hospital lactate ratio as a predictor of... more

Heart failure and COPD – Disentangling undertreatment from the impact of severe comorbidities

15 April 2026
Author(s): Henning Johann Steffen, Michael Behnes, Ibrahim Akin, Tobias Schupp

We read with great interest the study by Vauterin et al. investigating the association between guideline-directed medical therapy (GDMT) and mortality in patients with heart failure (HF) hospitalized... more

Redefining “isolated” Whipple’s disease: bridging the gap between clinical phenotype and pathophysiological reality

14 April 2026
Author(s): Changyong Chen, Kaiwei Zhang, Haozhu Chen, Ji Fei

We read with great interest the article by Eiferman et al., entitled “Isolated joint involvement in Whipple’s disease: a cohort study”, recently published in the European Journal of Internal Medicine... more

The paradox of increasing cardiac amyloidosis hospitalizations and persistent diagnostic delays

13 April 2026
Author(s): Artur Dziewierz, Michał Susuł, Renata Rajtar-Salwa

The recent population-based study by Ojeda-Fernández et al [1], provides a valuable and timely perspective on the evolving epidemiology of cardiac amyloidosis (CA). Leveraging two decades of... more

Advancing precision, accountability, and implementation in antithrombotic stewardship

11 April 2026
Author(s): Anuradha Mokkapati, Rhushvi Thakkar, Anjna Rani, Dinesh Puri

We read with great interest the perspective by Ageno et al. addressing the urgent need for antithrombotic stewardship (ATS) within contemporary healthcare systems [1]. The synthesis of global data... more

Systemic inflammation and frailty in cirrhosis: Considerations regarding the role of the systemic immune-inflammation index

10 April 2026
Author(s): İbrahim Ethem Güven

I read with great interest the study by Sogbe et al. entitled “Inflammatory spectrum of frailty: Association between the systemic immune-inflammation index and frailty in liver transplant candidates... more

Baseline asymptomatic bacteriuria in high-risk hematological patients: Does low concordance adequately reflect its true invasive potential?

7 April 2026
Author(s): Zhikai Zhang

We read with great interest the article by Tolosa-Ridao et al. published in the European Journal of Internal Medicine [1]. This study examined the prevalence of baseline asymptomatic bacteriuria... more

The Oral PCSK9 inhibitor enlicitide for hypercholesterolemia

14 March 2026
Author(s): Mohammed A. Elbahloul, Aliaa Gamal, Islam Y. Elgendy

Heterozygous familial hypercholesterolemia (HeFH) and other forms of severe hypercholesterolemia are characterized by lifelong elevation of low-density lipoprotein cholesterol (LDL-C), resulting in... more

Resting Heart Rate: a risk marker or factor for outcomes?

13 March 2026
Author(s): Elias Sanidas, Costas Thomopoulos

Resting heart rate (HR) remains one of the most routinely recorded yet paradoxically underappreciated cardiovascular parameters in clinical practice. Easily obtainable and highly reproducible, it... more

Training for prevention: exercise prescription as an Olympic discipline in the era of GLP-1 receptor agonists

10 March 2026
Author(s): Massimo Mapelli, Stefano Carugo, Elisabetta Salvioni, Piergiuseppe Agostoni

Dear Editor,

Causal inference and the risk of osmotic demyelination: A methodological critique of population-based hyponatremia research

9 March 2026
Author(s): Chunyan Chen

We read with great interest this population-based study derived from the Stockholm sodium cohort [1], which examined the association between early sodium correction rates in severe hyponatraemia and... more

Personalizing PFO closure decisions: The emerging role of the CRISP-PFO score

2 March 2026
Author(s): Zi Diao

We read with great interest the recent article by Rigatelli et al. in the European Journal of Internal Medicine, describing the development and validation of the CRISP-PFO score for optimizing... more

Prehospital-to-hospital lactate ratio in severe hyperglycemic emergencies: how far can one cutoff travel?

2 March 2026
Author(s): Ziren Xu

Sebastian-Valles et al. reported that a prehospital-to-hospital lactate ratio <1.23 identifies a subgroup of patients with severe hyperglycemic emergencies at markedly higher risk of in-hospital... more

Transparency regarding publication charges in leading medical journals

2 March 2026
Author(s): Jason Joe Baker, Siv Fonnes, Jacob Rosenberg, Jesper Ryg

The code of conduct for research transparency guides authors to preregister protocols, adhere to reporting guidelines, and fully disclose funding sources and conflicts [1]. Although article... more

Reconsidering “normal” in medicine

26 February 2026
Author(s): Marco Zuin, Gregory Piazza

“There are no norms. All people are exceptions to a rule that does not exist.”-Fernando Pessoa-

sTREM2 as an early MASH biomarker: a commentary on generalizability and mechanistic interpretation

24 February 2026
Author(s): Shiyu Peng, Shupeng Zhao, Hui Xiang, Yanling Wei

We read with great interest the study by Mahmoudian et al. investigating soluble TREM2 (sTREM2) as a non-invasive biomarker for early metabolic dysfunction-associated steatohepatitis (MASH) [1]. The... more

Long-term doctor–patient communication: a patient‑reported perspective from a large Italian survey

22 February 2026
Author(s): S. Harari, L. Ripamonti, P. Marveggio, P.M. Mannucci

Recent reports on long COVID and disability [1,2] have shown the value of large, patient‑reported web surveys in capturing dimensions of illness that are poorly described in traditional clinical... more

Rethinking scoring strategies for patient selection in PFO-related stroke

19 February 2026
Author(s): Yingxia Xie, Xueyuan Peng, Yuan Liu

We read with great interest the article regarding the CRISP-PFO score for optimizing patient selection for patent foramen ovale closure [1]. While refining risk stratification in patients with a Risk... more

Sotatercept for pulmonary arterial hypertension

18 February 2026
Author(s): Ahmed Samy Badran, Mohammed A. Elbahloul, Ahmed Sami Abuzaid, Islam Y. Elgendy

Pulmonary arterial hypertension (PAH) is a progressive, fatal disease driven by proliferative vascular remodeling. While current therapies targeting the endothelin, nitric oxide, and prostacyclin... more

Ostreopsis-related illness: An emerging and underrecognized clinical syndrome

17 February 2026
Author(s): Luca Bonanni, Marco Giannoccaro

Since the early 2000s, clusters of acute irritative and flu-like syndromes temporally associated with coastal exposure have been documented along Mediterranean shores, including Italy, France and... more

Reassessing SGLT2 Trials in HFpEF: When robustness and fragility coexist

13 February 2026
Author(s): Hu Liu, Qian Li, Hanning Zhang

Zuin and colleagues are to be commended for their rigorous reappraisal of sodium–glucose co-transporter 2 inhibitor (SGLT2i) trials in heart failure with preserved and mildly reduced ejection... more

Prevalence of aortic stenosis in patients with amyloidosis in northern Sweden

12 February 2026
Author(s): Kurt Boman, Mona Olofsson, Mathias Karlsson, Jonas Wixner

Amyloidosis and aortic stenosis seem to frequently occur together [1]. This has mainly been found in patients suffering from wild-type transthyretin amyloidosis (ATTRwt) [2]. It is still unclear... more

Access and Reimbursement Barriers to Guideline-Directed Cardiometabolic Therapy

12 February 2026
Author(s): Paschalis Karakasis, Dimitrios Patoulias, Antonios P Antoniadis, Nikolaos Fragakis, Ricardo Gómez-Huelgas

Cardiometabolic medicine is entering an era in which the most effective therapies are also among the least accessible. Glucagon-like peptide-1 receptor agonists (GLP-1RAs), sodium–glucose... more

Refining checklist-based screening for transthyretin cardiac amyloidosis: Methodological and pathophysiological considerations

10 February 2026
Author(s): Li Nie, Shu Liu, Fengxia Xu

We read with great interest the study by Pérez-Nieva and colleagues regarding the implementation of a systematic checklist-based strategy for the screening of transthyretin cardiac amyloidosis (ATTR-... more

Original Article

Lipoprotein(a) and risk of dementia: A propensity score–matched real-world analysis from a global federated research network

1 June 2026
Author(s): Michele Rossi, Enrico Tartaglia, Amir Askarinejad, Leandra Serio, Claudio Ferri, Tommaso Bucci, Gregory Y.H. Lip

The association between lipoprotein(a) [Lp(a)] and dementia remains controversial.

Association between hyponatremia and mortality in neurocritical patients with traumatic brain injury: A systematic review and meta-analysis

27 May 2026
Author(s): Erika Zornoza-González, Alicia Saz-Lara, Iván Cavero-Redondo, Andrea del Saz-Lara, Sara Valladolid-Ayllón, Óscar Martínez-Cifuentes, Ana González-Collado, Iris Otero Luis

Traumatic brain injury (TBI) is one of the leading causes of death and disability worldwide, especially among young adults, and represents a considerable health, economic, and social burden [1,2]. In... more

Efficacy of Aldosterone synthase inhibitors in uncontrolled and resistant hypertension: A systematic review and updated meta-analysis with grade assessment

23 April 2026
Author(s): Mrunalini Dandamudi, Alisha Ahmed, Muhammad Sharjeel Abbas, Muhammad Huzaifa Khattak, Navya Mandalapu, Terezia Toni Khairallah, Larissa Araújo de Lucena, Jonida Pjetrushaj

The current therapy for resistant hypertension is often limited by hyperkalemia, renal decline, and a failure to prevent compensatory increases in circulating aldosterone. The aldosterone synthase... more

Cocaine-induced ANCA-associated vasculitis: Cohort analysis from a referral center and literature review

21 April 2026
Author(s): Nuria Garvín Grande, María Pilar Ortiz-Lavín, Vanesa Calvo-Río, Fabricio Benavides-Villanueva, Carmelo Morales-Angulo, Juan Irure-Ventura, Diana Prieto-Peña, Victor M Martínez-Taboada, Ricardo Blanco

Cocaine adulterated with levamisole has been implicated as a trigger of Cocaine-Levamisole-Associated Autoimmune Syndrome (CLAAS), frequently mimicking granulomatosis with polyangiitis (GPA).

Venous thromboembolism risk assessment in hospital-at-home setting: A prospective cohort study (the TROMBODOM study)

18 April 2026
Author(s): Joao Modesto Dos Santos, Iñigo Les Bujanda, Paula Etayo-Urtasun, Julio Sánchez Álvarez, Mikel Izquierdo, Mikel L. Sáez De Asteasu, María Ruiz Castellano, Begoña Llorente Diez, Silvia Salinas Urra, Marta Pulido Fontes, Ramón Lecumberri

Venous thromboembolism (VTE) is a significant cause of preventable mortality in hospitalized patients. While risk assessment models such as Padua and IMPROVE-VTE scores have been validated in... more

Early brain biopsy in neurological diseases of unknown etiology improves functional outcome

13 April 2026
Author(s): Oumaima Aboubakr, Karima Mokhtari, Lucia Nichelli, Franck Bielle, Sophie Demeret, Anne-Laure Dubessy, Sonia Alamowitch, Marc Pineton De Chambrun, Alexandre Le Joncour, Valérie Pourcher, Ahmed Idbaih, Bertrand Mathon

Brain biopsy is established for diagnosing non-resectable neoplastic lesions, with yields approaching 95%, and for documenting brain infections [1,2]. However, the indications and timing of brain... more

Cause-specific mortality in patients with chronic pancreatitis: a nationwide population-based cohort study

10 April 2026
Author(s): Line Davidsen, Niels Henrik Bruun, Mathias E. Cook, Jens Brøndum Frøkjær, Asbjørn M. Drewes, Dhiraj Yadav, Søren S. Olesen

Cause-specific mortality in chronic pancreatitis changes over time. Early deaths are driven by pancreatitis-related deaths and liver disease, whereas extra-pancreatic cancers, respiratory, and... more

Shaping rheumatoid arthritis treatment: Clinical and demographic drivers of tsDMARDs versus bDMARDs prescription post-EMA pronouncement on JAK inhibitors. Insights from the AMBI-RA study

25 March 2026
Author(s): Riccardo Bertola, Beatrice Maranini, Carlo Garaffoni, Maria Pozzuto, Anna Laura Riva Cambrino, Alessandro Spinelli, Marcello Govoni, Alessandra Bortoluzzi, Ettore Silvagni

Rheumatoid arthritis (RA) is a chronic autoimmune disease leading to progressive joint damage and functional disability [1,2]. The treatment landscape for RA has evolved substantially over the last... more

Distinct miRNA expression profiles in subcutaneous and visceral adipose tissue of gastrointestinal cancer patients and their modulation based on adiposity level assessed by CT-scan

20 March 2026
Author(s): Federica Tambaro, Giovanni Imbimbo, Valentina Pace, Simona Orlando, Elena Belloni, Giuseppe Nigri, Veronica Rizzo, Orietta Picconi, Maria Ida Amabile, Maurizio Muscaritoli, Alessio Molfino

Metabolic and nutritional derangements during cancer are often characterized by significant loss of body weight, primarily due to the wasting of skeletal muscle and adipose tissue [1,2].

Long-term mortality in patients with first-time pulmonary embolism according to the presence of comorbidities at baseline: a nationwide register study

19 March 2026
Author(s): Mazdak Tavoly, Kristina Svennerholm, Jacob Philipson, Aldina Pivodic, Sam Schulman, Annika Rosengren, Maria Roupe, Katarina Glise Sandblad

Venous thromboembolism (VTE), encompassing pulmonary embolism (PE) and deep vein thrombosis (DVT), represents a significant global health burden due to high morbidity and mortality rates associated... more

Rituximab limits glucocorticoid use in IgG4-related disease: Real-world evidence from a large European cohort

19 March 2026
Author(s): Jens Vikse, Marco Lanzillotta, Elisabetta Goni, Bjørg-Tilde Svanes Fevang, Øyvind Midtvedt, Jasmin Mahajne, Veronica Batani, Giovanni Benanti, Georg Beyer, Lorenzo Dagna, Øyvind Molberg, Katrine Brække Norheim, Cathrine Brunborg, Ulf Schönermarck, Ivonne Regel, Julia Mayerle, Emanuel Della-Torre, Anna-Maria Hoffmann-Vold

While the rituximab-treated patients in this study had more severe IgG4-RD than the glucocorticoid-treated comparators, treatment with rituximab was associated with similar effectiveness endpoints,... more

Lifestyle characteristics and plasma biomarkers for risk of MASLD differ by sex in the general population

16 March 2026
Author(s): Lærke Kristine Kyhl, Børge Grønne Nordestgaard, Anne Tybjærg-Hansen, Michael Huy Cuong Pham, Jørgen Tobias Kühl, Klaus Fuglsang Kofoed, Sune Fallgaard Nielsen

The rise in global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) has highlighted the importance of developing sex-specific risk profiles for MASLD based on readily... more

Hydroxychloroquine for recurrent pericarditis: A multicentre observational study

16 March 2026
Author(s): Lucia Trotta, Francesco Agozzino, Silvia Berra, Ruggiero Mascolo, Francesco Rubuano, Olga Blagova, George Lazaros, Elisa Ceriani, Massimo Pancrazi, Angela Mauro, Emilia Lazarou, Nicola Marotta, Francesca Casarin, Ludovico L. Sicignano, Massimo Imazio, Antonio Brucato

To assess the effect of hydroxychloroquine (HCQ) in recurrent pericarditis (RP).

Optical coherence tomography angiography: a window on systemic sclerosis microangiopathy

14 March 2026
Author(s): Martina Orlandi, Tommaso Verdina, Filippo Santoro, Mohammed El Alouani, Matteo Gibertini, Mariagrazia Nuara, Alessandra Carobbio, Giorgia Roveta, Amelia Spinella, Marco De Pinto, Giuseppe Querques, Dilia Giuggioli

Systemic sclerosis (SSc) is a rare multisystem disease characterized by early microvascular damage that leads to fibrosis of skin and internal organs [1]. SSc-related ocular manifestations have been... more

Exercise testing in chronic thromboembolic pulmonary hypertension and chronic thromboembolic pulmonary disease without pulmonary hypertension: a comprehensive systematic review and meta-analysis

13 March 2026
Author(s): Filippo Biondi, Valerio Di Fiore, Roberta Pancani, Laura Carrozzi, Raffaele De Caterina, Rosalinda Madonna

The role of exercise testing in the follow up of patients with persistent dyspnea after pulmonary embolism (PE) is currently limited, with cardiopulmonary exercise test (CPET) mainly recommended in... more

All-cause mortality and early cardiovascular complications in relation to lesion location and stroke subtype in haemorrhagic and ischaemic stroke: the Perugia stroke registry

13 March 2026
Author(s): Andrea Galeazzo Rigutini, Maurizio Paciaroni, Maria Giulia Mosconi, Virginia Cancelloni, Chiara Urbini, Michele Marvardi, Carmen Rapuano, Allegra Gaboni, Alessandro Bufi, Tommaso Bucci, Cecilia Becattini, Gregory Y.H. Lip, Valeria Caso

Stroke is a major global cause of morbidity and mortality and is frequently complicated by early cardiovascular events, collectively referred to as stroke-heart syndrome (SHS)[1,2]. The SHS... more

Risk of infection shortly before and after a diagnosis of liver cirrhosis: a nationwide, population-based study in Sweden

10 March 2026
Author(s): Pia Anna Steimer, Axel Wester, Qing Shen, Hannes Hagström, Ying Shang

Liver cirrhosis is a serious medical condition and an increasing cause of mortality and morbidity worldwide [1–3] Cirrhosis poses a major burden on health systems, with patients having high risk of... more

Trends in cardiac amyloidosis hospital admissions and associated mortality risk over 20 years: a population-based study using healthcare administrative databases

25 February 2026
Author(s): Luisa Ojeda-Fernández, Claudio Cimminiello, Patrick Prada, Mauro Molteni, Mauro Tettamanti, Ida Fortino, Marta Baviera

Cardiac amyloidosis (CA) remains substantially underdiagnosed despite greater awareness. This study evaluated hospital admissions for CA as a proxy of its incidence in Lombardy over the last two... more

When social issues become medical emergencies: Prevalence and patient characteristics of social emergency admissions in internal medicine

25 February 2026
Author(s): MA Baumgartner, F Rutishauser, C Müller, M Boch, S Neuner-Jehle, BL Hug, PE Beeler

Hospitalisations constitute the largest share of healthcare expenditures, and recent evidence suggests that a growing number of admissions are driven primarily by non-acute or non-medical factors... more

Review Article

Human infection with Andes hantavirus: an update for the general physician

25 May 2026
Author(s): Emanuele Durante-Mangoni, Iolanda Cafarella, Silvia Mercadante, Nathalie Scarpulla, on behalf of the European Federation of Internal Medicine (EFIM) Infectious Diseases in Internal Medicine Working Group

Orthohantaviruses are zoonotic RNA-viruses transmitted to humans through inhalation of aerosols contaminated by infected rodent excreta. Among hantavirus species, Andes virus (ANDV) owns unique... more

Assessment and management of cardiovascular–kidney–liver metabolic-syndrome in the primary care setting: A multidisciplinary consensus statement

27 April 2026
Author(s): Reinhold Kreutz, Ali Canbay, Martin Haluzik, Andrzej Januszewicz, Juan M. Mendive, Pantelis Sarafidis, Jörn M. Schattenberg

The recently introduced cardiovascular–kidney–metabolic (CKM) syndrome captures the close interplay between metabolic risk factors, chronic kidney disease, and cardiovascular disease, but... more

Trigger-induced atrial fibrillation for the hospitalist: a review

13 April 2026
Author(s): Barat S. Venkataramany, Aparna Kambhampati, Alexander Arora, Sarah Horn

Atrial fibrillation (AF) is a common arrhythmia that a hospitalist may encounter. It is known to occur transiently or in response to specific triggers (trigger-induced AF), which presents a challenge... more

“Unpatients” in haemostasis and thrombosis. A yardstick of current paths in healthy carriers of a genetic susceptibility

8 April 2026
Author(s): G. Di Minno

Thrombophilia is defined as either an inherited or acquired abnormality of haemostasis inclining affected subjects to thrombosis, mainly because of interaction of multiple inherited and/or acquired... more

Alcohol use: less is better. An umbrella systematic review of clinical interventions, policies, and dose–response health risks in adults

24 March 2026
Author(s): Tommaso Dionisi, Vittorio De Vita, Giovanna Di Sario, Antonio Gasbarrini, Giovanni Addolorato, the“Alcohol Research” Group

Alcohol is a major modifiable cause of morbidity, premature mortality and health inequalities, yet evidence informing “low-risk” thresholds and prevention strategies is fragmented.

Chronic therapeutic non-adherence: Toward a new nosological entity

16 March 2026
Author(s): Federica Moscucci, Francesco Baratta, Stefano Necozione, Giovambattista Desideri

In 2021, non-communicable diseases caused approximately 43.8 million deaths and 1.73 billion DALYs globally, posing a major challenge for healthcare systems [1]. Despite significant advances in... more

Special Article

Reassessing venous thromboembolism risk in the hospital-at-home era: Toward tailored, context-specific assessment

16 May 2026
Author(s): Paolo Prandoni

Venous thromboembolism (VTE) continues to represent a leading cause of preventable morbidity and mortality among acutely ill medical patients [1]. Effective thromboprophylaxis remains a cornerstone... more

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness